These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 36333388)

  • 21. Alternative polyadenylation associated with prognosis and therapy in colorectal cancer.
    Zhang Y; Xu Y; Wang Y
    Sci Rep; 2022 Apr; 12(1):7036. PubMed ID: 35487956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
    Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
    Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
    Yu S; Chen M; Xu L; Mao E; Sun S
    Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma.
    Luo D; Feng W; Ma Y; Jiang Z
    Sci Rep; 2022 Aug; 12(1):14729. PubMed ID: 36042374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
    Li J; Li X; Zhang C; Zhang C; Wang H
    Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosome secretion related gene signature predicts chemoresistance in patients with colorectal cancer.
    Ming L; Tang J; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Pathol Res Pract; 2024 May; 257():155313. PubMed ID: 38642509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients.
    Zhu W; Wu C; Hu S; Liu S; Zhao S; Zhang D; Qiu G; Cheng X; Huang J
    Sci Rep; 2023 Dec; 13(1):21358. PubMed ID: 38049474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.